RT Journal Article
SR Electronic
T1 Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000453
DO 10.1136/jitc-2019-000453
VO 8
IS 1
A1 Desai, Jayesh
A1 Deva, Sanjeev
A1 Lee, Jong Seok
A1 Lin, Chia-Chi
A1 Yen, Chia-Jui
A1 Chao, Yee
A1 Keam, Bhumsuk
A1 Jameson, Michael
A1 Hou, Ming-Mo
A1 Kang, Yoon-Koo
A1 Markman, Ben
A1 Lu, Chang-Hsien
A1 Rau, Kun-Ming
A1 Lee, Kyung-Hun
A1 Horvath, Lisa
A1 Friedlander, Michael
A1 Hill, Andrew
A1 Sandhu, Shahneen
A1 Barlow, Paula
A1 Wu, Chi-Yuan
A1 Zhang, Yun
A1 Liang, Liang
A1 Wu, John
A1 Paton, Virginia
A1 Millward, Michael
YR 2020
UL http://jitc.bmj.com/content/8/1/e000453.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.